1. Introduction

The alteration of human personality through biotechnology is an emerging issue in medical law, bioethics, constitutional law, human rights law and civil liability.

Personality refers to the distinctive psychological and behavioural characteristics of an individual, including:

Thoughts, beliefs and attitudes.

Emotional responses and temperament.

Memory and personal identity.

Decision-making capacity.

Behavioural patterns and preferences.

Moral judgments and individual autonomy.

Biotechnology may influence or alter these characteristics through genetic engineering, neurotechnology, brain stimulation, pharmaceutical interventions, neural implants, gene therapy and other biomedical techniques.

For example, a biotechnology company might develop a neural implant intended to reduce aggression. However, the treatment could unintentionally suppress emotional responses, alter a person's preferences or change their behavioural characteristics.

This raises an important legal question:

Who should be legally responsible when biotechnology changes a person's personality without valid consent, or causes an unintended alteration of their psychological identity?

Potentially responsible parties include:

Biotechnology manufacturers.

Medical practitioners and surgeons.

Hospitals and research institutions.

Pharmaceutical companies.

Genetic engineering laboratories.

Clinical trial sponsors.

Researchers and technology developers.

The central legal principles are bodily autonomy, informed consent, personal liberty, medical negligence, product liability, privacy, dignity and the right to psychological integrity.

Important legal qualification: There is no comprehensive, universally accepted legal framework specifically governing liability for biotechnology-induced personality alteration. The issue must therefore be examined through established principles of medical negligence, constitutional rights, informed consent, product liability and human rights.

2. Meaning of Personality Alteration Through Biotechnology

Personality alteration through biotechnology means an intentional or unintended modification of an individual's psychological, emotional, cognitive or behavioural characteristics through biological or technological intervention.

Major forms of biotechnology-related personality alteration

A. Genetic modification

Genetic engineering may influence biological characteristics associated with neurological development, emotional regulation or behaviour.

If an intervention produces unexpected psychological consequences, questions may arise regarding informed consent, scientific negligence and the responsibility of the research institution.

B. Neurotechnology and brain stimulation

Deep Brain Stimulation | Stereotactic and Functional Neurosurgery | IU School of Medicine

medicine.iu.edu

Deep brain stimulation (DBS), neural implants and other neurological technologies can influence brain circuits associated with movement, mood, motivation and behaviour.

Potential legal concerns include:

Unintended behavioural changes.

Impaired judgment.

Altered emotional responses.

Loss of control over implanted devices.

Failure to disclose psychological risks.

C. Pharmaceutical personality modification

Certain medicines acting on the central nervous system may affect mood, emotional responses, motivation, cognition and behaviour.

Where a practitioner prescribes such medication without adequate assessment, monitoring or disclosure of material risks, medical negligence may arise.

D. Gene therapy and neurological intervention

Advancements and Challenges in Bioprocessing for Viral-Vector Gene Therapy Manufacturing - European Pharmaceutical Manufacturer

pharmaceuticalmanufacturer.media

Gene therapy may influence biological processes relevant to neurological functioning.

If an intervention produces an unexpected alteration in personality, liability may depend on whether the intervention was scientifically justified, properly tested, adequately disclosed and administered according to accepted medical standards.

E. Artificial intelligence-assisted neurobiotechnology

AI-supported neurological devices may monitor or influence brain activity.

Potential problems include unauthorized manipulation, defective algorithms, inadequate safeguards and failure to prevent foreseeable psychological harm.

3. Legal Foundations of Liability in India

The Indian legal framework can be examined under the following provisions.

A. Article 21 – Right to Life and Personal Liberty

Article 21 of the Constitution of India protects life and personal liberty.

Its interpretation extends beyond mere physical survival and includes:

Human dignity.

Bodily integrity.

Personal autonomy.

Privacy.

Freedom of thought.

Psychological integrity.

The ability to make important decisions concerning one's own life.

If the State or a State-controlled institution subjects an individual to personality-altering biotechnology without lawful justification, constitutional challenges may arise.

Private biotechnology companies and private hospitals are not automatically directly liable under Article 21 in the same manner as the State. Their conduct may, however, attract statutory, contractual and tortious liability, while constitutional principles inform the protection of individual rights.

Important case:

Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

The nine-judge Bench of the Supreme Court recognised privacy as a fundamental right.

The judgment explained that privacy protects the autonomy of the body and mind and the individual's ability to make decisions concerning important aspects of life.

It also recognised the relationship between mental integrity, freedom of thought, dignity and self-determination.

Application: If biotechnology changes an individual's thoughts, preferences or psychological identity without meaningful consent, the principles of Puttaswamy provide a substantial constitutional foundation for challenging State interference and interpreting related legal protections.

Indian Kanoon+1

B. Article 19 – Freedom of Expression and Thought

Article 19 protects several freedoms, including freedom of speech and expression under Article 19(1)(a).

Personality-altering biotechnology may interfere with the individual's ability to:

Form independent opinions.

Express personal beliefs.

Maintain intellectual independence.

Communicate freely.

Exercise personal choices.

For example, suppose a government institution uses neurotechnology to suppress particular thoughts or influence the political beliefs of individuals.

Such conduct could raise serious constitutional questions involving freedom of expression, privacy and personal autonomy.

However, Article 19 does not create an unlimited right against every medical intervention that affects mental functioning. The particular interference and its constitutional justification must be examined.

C. Article 14 – Right to Equality

Article 14 prohibits arbitrary State action and guarantees equality before the law.

Potential violations may arise if:

Biotechnology is imposed selectively on particular groups.

Individuals are subjected to personality modification without rational justification.

Certain persons are denied access to treatment on discriminatory grounds.

Government institutions use psychological modification as a coercive measure.

D. Indian Contract Act, 1872

The Indian Contract Act may become relevant when a person enters into an agreement for biotechnology treatment.

Important provisions include:

Example: A biotechnology clinic promises that a neural intervention will improve concentration without changing personality. It deliberately conceals known risks of severe emotional changes.

The patient may have grounds to challenge the validity of consent and seek appropriate contractual remedies, depending on the evidence and circumstances.

An agreement cannot automatically legalise an intervention that violates applicable law or fundamental legal protections.

E. Consumer Protection Act, 2019

Biotechnology treatment may constitute a service within the meaning of consumer protection legislation.

A patient may pursue a consumer complaint where the statutory requirements are satisfied and the treatment involves:

Deficiency in medical services.

Negligent administration of biotechnology.

Misleading representations.

Defective medical devices.

Unfair trade practices.

Failure to provide promised services.

Product liability provisions under the Act may also be relevant to defective biotechnology products and medical devices, subject to the statutory definitions, exclusions and applicable defences.

4. Liability for Absence of Informed Consent

Major ground of liability

Informed consent is particularly important where biotechnology can affect a person's psychological identity.

A patient should receive appropriate information about the nature, purpose, expected benefits, material risks and reasonable alternatives to a proposed intervention.

In personality-altering procedures, relevant disclosures may include:

The possibility of emotional instability.

Changes in memory or cognitive functioning.

Possible behavioural changes.

Changes in motivation or emotional responsiveness.

Potential effects on decision-making capacity.

Possibility of permanent or irreversible consequences.

Available alternatives and the option of refusing treatment.

Leading case: Samira Kohli v. Dr. Prabha Manchanda

Citation: (2008) 2 SCC 1.

'Even Ajmal Kasab was given fair trial': Supreme Court to CBI in Yasin Malik's case - India News | The Financial Express

financialexpress.com

Facts:

The patient, Samira Kohli, underwent a diagnostic medical procedure. While she was under anaesthesia, the doctor performed a more extensive operation involving the removal of her reproductive organs without obtaining her consent.

Legal issue:

Whether consent for a diagnostic procedure could authorise a substantially different therapeutic operation.

Judgment:

The Supreme Court held that consent must be real and valid. It must be voluntary, given by a competent patient and based on adequate information about the nature of the procedure.

Consent for a diagnostic procedure cannot ordinarily be treated as consent for an additional therapeutic procedure.

An additional procedure without consent may be justified in narrowly defined emergency circumstances where delay would be unreasonable and necessary to save life or preserve health.

Application to biotechnology:

Suppose a patient consents to a neurological implant to control tremors, but the surgeon also activates a personality-modification programme without separate authorisation.

The reasoning in Samira Kohli supports the argument that consent to one medical intervention does not automatically authorise a materially different intervention.

A patient may seek compensation for unauthorised treatment, even where the doctor believes that the additional intervention is beneficial.

Indian Kanoon+2

Legal consequences of invalid consent

Where personality alteration occurs without valid consent, possible legal consequences include:

Civil liability for unauthorized medical intervention.

Compensation for physical and psychological injury.

Consumer proceedings for deficiency in service.

Professional disciplinary proceedings.

Criminal liability where the facts satisfy the ingredients of an applicable offence.

Constitutional remedies where State action violates fundamental rights.

Importantly, a change in personality alone does not automatically establish negligence. The claimant must establish the relevant legal basis of liability.

5. Liability for Medical Negligence

Medical negligence arises when a medical practitioner fails to exercise the degree of reasonable skill and care expected in the circumstances, causing legally recognised harm.

In biotechnology-related personality alteration, negligence may arise in several ways.

A. Negligent selection of treatment

A doctor may recommend a personality-affecting procedure without properly evaluating the patient's condition, medical history or suitability.

B. Negligent performance

A surgeon may incorrectly implant, programme or operate a neural device.

C. Failure to monitor psychological changes

A practitioner may ignore warning signs of:

Severe mood instability.

Unusual impulsive behaviour.

Cognitive deterioration.

Personality disturbance.

Loss of behavioural control.

D. Failure to discontinue or adjust treatment

Where a practitioner becomes aware of serious adverse psychological effects but fails to take reasonable corrective measures, negligence may arise.

E. Failure to explain risks

A doctor may be liable where the applicable consent and professional-care standards have not been satisfied.

Important case laws

1. Jacob Mathew v. State of Punjab (2005) 6 SCC 1

The Supreme Court explained the principles governing medical negligence and the standard of care expected from medical professionals.

The judgment discussed the need to establish a failure to exercise reasonable skill and care, rather than treating every unsuccessful medical outcome as negligence.

Application: A doctor administering personality-altering biotechnology may be liable if the treatment falls below the applicable standard of professional care and causes foreseeable injury.

2. Kusum Sharma v. Batra Hospital & Medical Research Centre (2010) 3 SCC 480

The Supreme Court discussed the principles for determining medical negligence.

It recognised that medical professionals should not be held liable merely because a treatment produces an unsuccessful result or because another medical approach might have been preferred.

Application: An unexpected personality change following a properly conducted and adequately disclosed treatment will not automatically establish negligence. The court must examine the professional standard, available scientific knowledge and circumstances.

3. Indian Medical Association v. V.P. Shantha (1995) 6 SCC 651

The Supreme Court examined the applicability of consumer protection legislation to medical services.

The decision established that medical services falling within the relevant statutory framework may be subject to consumer jurisdiction.

Application: A patient suffering psychological injury from deficient biotechnology treatment may pursue a consumer remedy where the statutory conditions are fulfilled.

Indian Kanoon+1

6. Product Liability of Biotechnology Manufacturers

A biotechnology manufacturer may be held responsible when a defective product causes psychological or personality-related injury.

The Consumer Protection Act, 2019 is particularly important in this context.

Relevant statutory provisions

Section 82 – Application of product liability chapter

Provides for claims involving harm caused by defective products manufactured, serviced or sold by relevant parties.

Section 83 – Product liability action

Allows a complainant to bring a product liability action against a manufacturer, product service provider or product seller.

Section 84 – Liability of product manufacturer

A manufacturer may be liable where:

The product contains a manufacturing defect.

The product has a defective design.

It deviates from manufacturing specifications.

It fails to conform to an express warranty.

It lacks adequate instructions or warnings.

Section 85 – Liability of product service provider

A product service provider may be liable for deficient services, negligence, withholding relevant information or failure to provide adequate instructions and warnings.

Section 86 – Liability of product sellers

A seller may be liable in specified circumstances, including where the seller substantially controls the product's design or testing, modifies the product in a causally significant way, or fails to exercise the required care.

Section 87 – Exceptions

Provides specified exceptions and limitations to product liability claims.

India Code+1

Example: Defective neural implant

Suppose a company manufactures a neural implant designed to regulate emotional instability.

Due to a software defect, the device causes:

Severe emotional suppression.

Impulsive behaviour.

Disturbances in memory.

Significant changes in personality.

The patient may bring proceedings against the manufacturer if the statutory requirements for product liability are established.

The manufacturer may face liability for:

Defective product design.

Manufacturing defects.

Failure to provide adequate warnings.

Inaccurate product representations.

Failure to meet applicable safety requirements.

Who can be held liable?

The liability of each party depends on its actual role, the applicable statute and proof of causation.

7. Liability for Psychological and Emotional Injury

Personality alteration may cause psychological harm even when there is no obvious physical injury.

Examples include:

Loss of emotional responsiveness.

Severe anxiety or depression.

Changes in memory and identity.

Loss of motivation.

Impaired social relationships.

Unusual aggression.

Loss of personal independence.

Psychological distress caused by involuntary behavioural changes.

A claimant may seek damages where the injury is legally recognised and supported by appropriate evidence.

Important legal considerations

1. Proof of injury

The claimant should establish the nature and extent of the psychological injury through medical records, psychiatric evaluations, expert evidence and other relevant material.

2. Causation

It must be established that the biotechnology intervention caused or materially contributed to the alleged harm under the applicable legal test.

3. Foreseeability

The court may consider whether the injury was reasonably foreseeable in the circumstances.

4. Permanence

Permanent personality changes may affect the assessment of compensation, although temporary psychological injury can also be compensable.

5. Financial consequences

The claimant may seek compensation for reasonable treatment costs, loss of earnings and other legally recoverable losses.

8. Liability for Genetic and Neurotechnological Experimentation

Experimental biotechnology presents special legal concerns because the intervention may have uncertain long-term consequences.

A researcher or institution may face liability where it:

Conducts experimentation without valid consent.

Fails to obtain necessary regulatory approvals.

Conceals material risks.

Uses an unsafe experimental procedure.

Fails to provide required medical monitoring.

Deviates from the approved research protocol.

Fails to provide applicable compensation for research-related injury.

Relevant Indian legal framework

The following regulatory instruments may be relevant, depending on the intervention:

New Drugs and Clinical Trials Rules, 2019.

Applicable ICMR National Ethical Guidelines.

Applicable rules governing biomedical and health research.

Medical Devices Rules, 2017.

Applicable requirements under the Drugs and Cosmetics Act, 1940.

Applicable biotechnology and biosafety regulations.

Not every experimental biotechnology intervention falls under every one of these instruments. The classification of the intervention determines the applicable regulatory framework.

Important distinction

There is a difference between:

Therapeutic personality alteration intended to treat a medical condition.

Experimental personality alteration undertaken to test scientific hypotheses.

Non-therapeutic personality modification undertaken to change an individual's behaviour or identity.

The requirements for consent, ethical review, risk assessment and regulatory compliance may differ between these situations.

9. Criminal Liability for Unauthorised Personality Modification

In serious circumstances, personality alteration through biotechnology may also raise criminal-law issues.

The applicable provisions of the Bharatiya Nyaya Sanhita, 2023 may become relevant where the conduct satisfies the ingredients of an offence.

Potentially relevant offences include:

Voluntarily causing hurt.

Voluntarily causing grievous hurt.

Causing hurt or grievous hurt by dangerous means.

Criminal force or assault.

Cheating through deliberate deception.

Criminal intimidation, where applicable.

The exact offence depends on the conduct, intention or knowledge, resulting injury and other statutory requirements.

For instance, deliberately administering a dangerous biological substance to alter another person's behaviour without lawful authority may constitute a criminal offence if its statutory elements are proved.

Important distinction: An adverse medical outcome does not automatically constitute a criminal offence. Criminal negligence requires the applicable criminal-law standard to be established.

Relevant case: Jacob Mathew v. State of Punjab (2005) 6 SCC 1

The Supreme Court distinguished civil medical negligence from criminal medical negligence.

It explained that criminal prosecution of medical professionals requires a sufficiently high degree of negligence, rather than an ordinary error of judgment.

Application: A doctor whose properly performed biotechnology procedure produces an unexpected personality change is not automatically criminally liable. Deliberate wrongdoing or the requisite degree of criminal negligence must be established.

Indian Kanoon+1

10. Liability When Biotechnology Changes Personal Identity and Decision-Making Capacity

This is one of the most complicated aspects of personality-altering biotechnology.

Suppose a patient undergoes brain stimulation to treat a neurological disorder. After the procedure, the patient experiences substantial changes in:

Impulse control.

Emotional stability.

Risk-taking behaviour.

Moral judgment.

Decision-making capacity.

The legal question is whether the patient continues to possess the same level of responsibility and legal capacity as before the intervention.

A. Medical decision-making capacity

A person may experience changes in decision-making capacity after neurological treatment.

A practitioner should assess the patient's ability to understand, retain and evaluate relevant information and communicate a decision, as applicable under the governing law.

A person's personality changing does not automatically mean that the person has lost legal capacity.

B. Responsibility for subsequent conduct

Suppose a neural implant causes severe impulsivity, and the patient subsequently commits an act causing injury to another person.

The court may need to consider:

Whether the individual had the requisite criminal intention or knowledge.

Whether the individual suffered from a legally recognised mental condition.

Whether the biotechnology contributed to the conduct.

Whether the patient understood the nature and consequences of the act.

Whether the intervention was defective or negligently administered.

C. Responsibility of the manufacturer and medical practitioner

If the device was defective or the treatment was negligently administered, the manufacturer or practitioner may separately face civil liability.

However, the patient's criminal responsibility and the medical practitioner's civil liability are separate legal questions.

Relevant case law

Dahyabhai Chhaganbhai Thakkar v. State of Gujarat (1964) 7 SCR 361

The Supreme Court discussed the insanity defence and the burden of proof under Section 84 of the Indian Penal Code, the predecessor of the corresponding provision in the Bharatiya Nyaya Sanhita, 2023.

The decision is relevant to the assessment of legal responsibility where a person's mental condition affects the capacity required for criminal responsibility.

Application: Biotechnology-induced mental changes may become relevant evidence in assessing criminal responsibility. However, a personality change by itself does not establish legal insanity.

Academic and comparative authority: Deep Brain Stimulation

The scholarly article Did My Brain Implant Make Me Do It? Questions Raised by DBS Regarding Psychological Continuity, Responsibility for Action and Mental Competence examines how deep brain stimulation may affect psychological continuity, personal identity and responsibility for conduct.

It is particularly relevant because it directly addresses the legal and ethical questions created by DBS-induced personality changes.

PubMed

11. Important Comparative Case Laws

Although these cases do not specifically concern biotechnology-induced personality alteration, they provide useful legal principles for analysing such disputes.

A. Montgomery v. Lanarkshire Health Board (2015)

Citation: [2015] UKSC 11.

Court: Supreme Court of the United Kingdom.

Legal principle: Disclosure of material medical risks.

The Court held that doctors must take reasonable care to ensure that patients are aware of material risks associated with proposed treatment and reasonable alternative treatments.

Application: If a doctor knows that a neurological intervention carries a significant risk of permanently altering personality, that risk may be material and should be disclosed.

This is a persuasive comparative authority, not a binding Indian Supreme Court precedent.

Bailii+1

B. Re C (Adult: Refusal of Treatment) (1994)

Citation: [1994] 1 WLR 290.

Court: High Court of England and Wales.

Legal principle: Mental illness does not automatically eliminate decision-making capacity.

The Court considered whether the patient could understand, retain and weigh information concerning medical treatment and communicate a decision.

Application: A person whose personality has changed following biotechnology must not automatically be presumed incapable of making medical decisions. Capacity must be individually assessed.

PubMed+1

C. Suchita Srivastava v. Chandigarh Administration (2009)

Citation: (2009) 9 SCC 1.

Court: Supreme Court of India.

Legal principle: Reproductive autonomy and personal liberty under Article 21.

The Supreme Court recognised the importance of reproductive choice and held that the relevant decision could not be made without respecting the woman's consent.

Application: The decision supports the broader principle that medical intervention affecting intimate aspects of an individual's personhood must respect personal autonomy.

Indian Kanoon+1

12. Types of Compensation and Legal Remedies

An individual suffering personality alteration because of an unlawful or negligent biotechnology intervention may seek different forms of legal relief.

Constitutional remedies

Where State action violates fundamental rights, an affected person may approach the appropriate constitutional court.

Article 32: Supreme Court of India.

Article 226: High Courts.

Depending on the circumstances, courts may consider appropriate directions, declarations or compensation for established violations of fundamental rights.

Civil remedies

A claimant may pursue an appropriate civil action based on:

Negligence.

Battery or unauthorized medical intervention.

Breach of contractual obligations.

Defective products.

Deficiency in medical services.

The choice of remedy depends on the facts and the applicable legal framework.

13. Defences Available to Biotechnology Companies and Medical Practitioners

Not every personality change following biotechnology creates legal liability.

Defendants may raise several defences.

1. Valid informed consent

The patient voluntarily agreed to the procedure after receiving adequate information about its material risks.

However, consent does not excuse negligence or authorise conduct beyond its scope.

2. Absence of negligence

The treatment was performed in accordance with the applicable professional standard of care.

3. Scientific uncertainty

The psychological effect was genuinely unforeseeable in light of the scientific knowledge reasonably available at the relevant time.

4. Absence of causation

The personality change resulted from an independent medical condition or another intervening cause.

5. Patient misuse

The patient or another person misused or improperly modified the device, potentially engaging applicable statutory defences.

6. Emergency necessity

An intervention was reasonably necessary in an emergency where valid consent could not be obtained and applicable legal requirements were satisfied.

7. Contributory negligence

Where recognised under the applicable legal framework, the defendant may argue that the claimant's own conduct contributed to the harm.

The availability and effect of these defences depend on the particular cause of action.

14. Hypothetical Legal Case Study

Consider the following situation.

Case: Unauthorised personality modification through a neural implant

A 32-year-old individual undergoes a neurological procedure intended to treat severe tremors.

The hospital uses a biotechnology device manufactured by Company X.

After implantation, the device is programmed with an additional experimental function that influences emotional responses.

The patient experiences:

Significant emotional instability.

Unusual aggressive behaviour.

Loss of emotional attachment.

Changes in decision-making.

Serious disruption of family relationships.

The patient alleges that the experimental function was never explained or authorised.

Potential legal analysis

Possible outcome: If the patient proves unauthorised intervention, defective programming or negligent medical treatment, the responsible parties may face civil or consumer liability. Criminal proceedings may also be possible if the facts establish a statutory offence.

15. Major Challenges in Determining Liability

Personality-altering biotechnology creates several difficulties for courts.

A. Difficulty in defining personality

Personality is complex and may change naturally over time. Courts must distinguish ordinary psychological development from treatment-induced alteration.

B. Difficulty in establishing causation

A patient's personality may be influenced by genetics, medication, environmental factors, neurological conditions and psychological experiences.

C. Lack of specific legislation

Indian law does not presently provide a comprehensive, dedicated statutory regime for liability arising specifically from biotechnology-induced personality alteration.

D. Scientific uncertainty

The long-term consequences of advanced neurotechnology and genetic interventions may not be fully understood.

E. Multiple responsible parties

The manufacturer, programmer, hospital, researcher and treating practitioner may each have different responsibilities.

F. Irreversible consequences

Some interventions may create psychological changes that cannot easily be reversed, making the assessment of damages particularly difficult.

16. Suggestions for Legal and Regulatory Reform

A specialised legal framework could address the risks of personality-altering biotechnology through the following safeguards.

1. Specific informed-consent requirements: Separate consent for interventions intended to influence personality, emotional functioning or cognition.

2. Psychological risk disclosure: Mandatory disclosure of known material risks involving behavioural and emotional changes.

3. Independent ethical review: Enhanced scrutiny of experimental neurological and genetic interventions.

4. Post-treatment monitoring: Long-term monitoring where scientifically justified and proportionate.

5. Manufacturer accountability: Stronger safety, testing, warning and reporting requirements for relevant biotechnology products.

6. Protection against coercion: Prohibition of non-consensual personality modification except where a legally recognised exception applies.

7. Compensation mechanisms: Effective procedures for individuals suffering research-related or treatment-related injuries.

8. Protection of mental privacy: Safeguards against unauthorised access to neural data, psychological information and behavioural records.

9. Independent assessment of capacity: Procedures for determining decision-making capacity without automatically equating personality change with incapacity.

17. Summary of Important Case Laws

18. Conclusion

Liability for altering personality through biotechnology represents an important emerging area of medical jurisprudence.

The fundamental legal principle is that a person's psychological identity, mental autonomy and bodily integrity deserve legal protection just as much as their physical health.

Biotechnology companies, hospitals, medical practitioners and researchers must exercise appropriate care when developing or administering interventions capable of changing human personality.

In India, Articles 14, 19 and 21 of the Constitution, the Indian Contract Act, 1872, the Consumer Protection Act, 2019, the Bharatiya Nyaya Sanhita, 2023 and established medical negligence principles provide the principal legal foundations for addressing these disputes.

The judgments in Puttaswamy, Samira Kohli, Jacob Mathew and Suchita Srivastava are particularly useful in constructing the legal argument.

Ultimately, technological advancement cannot be treated as a justification for overriding individual autonomy. A person should not be deprived of control over their psychological identity through unauthorised, deceptive or negligently administered biotechnology.

The central principle is that biotechnology may seek to improve human functioning, but it must respect the individual's right to dignity, informed choice and personal identity.

Academic note: The case laws discussed above establish general legal principles rather than a settled body of Indian precedents specifically imposing liability for biotechnology-induced personality changes. The application of these principles to advanced genetic and neurotechnological interventions remains an evolving legal question.

I can also develop this subject into a detailed law-school research paper with statutory provisions, judicial reasoning, comparative international law and footnote-style case citations.